In Hindustan Times, OHT’s Dr. Ramanan Laxminarayan calls attention to India’s urgent need for stronger oversight of drug manufacturing, following the tragic deaths of at least 20 children in Madhya Pradesh and Rajasthan, India, after consuming contaminated cough syrup.

“The government must act decisively. The Coldrif tragedy should be the last time a parent loses a child to a preventable regulatory failure. Passing the new Bill swiftly — and ensuring its rigorous enforcement — would honour both India’s role as the world’s pharmacy and its duty to protect every life that depends on it.”

Read more here.